Mazapertine

From WikiMD's WELLNESSPEDIA

File:Mazapertine.svg
Mazapertine.svg

Mazapertine is an antipsychotic medication that belongs to the class of atypical antipsychotics. It is primarily used in the treatment of schizophrenia and other psychotic disorders. Mazapertine is known for its unique pharmacological profile, which includes a combination of dopamine and serotonin receptor antagonism.

Pharmacology[edit]

Mazapertine acts on multiple neurotransmitter systems in the brain. It primarily functions as an antagonist at the dopamine D2 receptors and serotonin 5-HT2A receptors. This dual action is believed to contribute to its efficacy in reducing both positive and negative symptoms of schizophrenia.

Mechanism of Action[edit]

The mechanism of action of Mazapertine involves blocking the dopamine D2 receptors, which helps in reducing the overactivity of dopamine that is often associated with psychotic symptoms. Additionally, its antagonistic effect on serotonin 5-HT2A receptors helps in modulating mood and cognitive functions, which can be beneficial in treating the negative symptoms of schizophrenia.

Indications[edit]

Mazapertine is indicated for the treatment of:

Side Effects[edit]

Common side effects of Mazapertine include:

Less common but more serious side effects may include:

Dosage and Administration[edit]

Mazapertine is typically administered orally. The dosage varies depending on the severity of the condition being treated and the patient's response to the medication. It is important to follow the prescribing physician's guidelines and adjust the dosage as necessary.

Contraindications[edit]

Mazapertine is contraindicated in patients with:

Interactions[edit]

Mazapertine may interact with other medications, including:

Research and Development[edit]

Mazapertine is still under investigation for its full range of therapeutic effects and potential new indications. Ongoing research aims to better understand its long-term efficacy and safety profile.

See Also[edit]

References[edit]


Template:Psychotropic drug-stub